A detailed history of Oppenheimer Asset Management Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 21,983 shares of EW stock, worth $1.43 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
21,983
Previous 21,368 2.88%
Holding current value
$1.43 Million
Previous $2.04 Million 0.54%
% of portfolio
0.03%
Previous 0.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$84.3 - $94.31 $51,844 - $58,000
615 Added 2.88%
21,983 $2.03 Million
Q1 2024

May 06, 2024

BUY
$72.54 - $95.56 $435 - $573
6 Added 0.03%
21,368 $2.04 Million
Q4 2023

Feb 13, 2024

SELL
$61.71 - $77.76 $4.1 Million - $5.17 Million
-66,450 Reduced 75.67%
21,362 $1.63 Million
Q3 2023

Nov 07, 2023

BUY
$69.28 - $93.38 $327,209 - $441,033
4,723 Added 5.68%
87,812 $6.08 Million
Q2 2023

Aug 02, 2023

SELL
$81.41 - $94.33 $145,805 - $168,945
-1,791 Reduced 2.11%
83,089 $7.84 Million
Q1 2023

May 10, 2023

SELL
$74.26 - $84.51 $65,645 - $74,706
-884 Reduced 1.03%
84,880 $7.02 Million
Q4 2022

Feb 06, 2023

BUY
$68.3 - $87.44 $149,440 - $191,318
2,188 Added 2.62%
85,764 $6.4 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $153,784 - $200,310
1,867 Added 2.28%
83,576 $6.91 Million
Q2 2022

Aug 08, 2022

SELL
$86.5 - $128.27 $559,914 - $830,291
-6,473 Reduced 7.34%
81,709 $7.77 Million
Q1 2022

May 12, 2022

BUY
$101.96 - $128.34 $113,991 - $143,484
1,118 Added 1.28%
88,182 $10.4 Million
Q4 2021

Feb 02, 2022

BUY
$106.37 - $130.68 $112,007 - $137,606
1,053 Added 1.22%
87,064 $11.3 Million
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $16,877 - $20,131
164 Added 0.19%
86,011 $9.74 Million
Q2 2021

Aug 03, 2021

BUY
$83.84 - $104.76 $166,673 - $208,262
1,988 Added 2.37%
85,847 $8.89 Million
Q1 2021

May 17, 2021

SELL
$78.68 - $90.67 $705,130 - $812,584
-8,962 Reduced 9.66%
83,859 $7.01 Million
Q4 2020

Feb 11, 2021

BUY
$71.69 - $91.23 $284,824 - $362,456
3,973 Added 4.47%
92,821 $8.47 Million
Q3 2020

Nov 13, 2020

BUY
$67.19 - $87.44 $191,155 - $248,766
2,845 Added 3.31%
88,848 $7.09 Million
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $3.31 Million - $4.43 Million
57,509 Added 201.83%
86,003 $5.94 Million
Q1 2020

May 08, 2020

SELL
$52.41 - $81.0 $212,208 - $327,969
-4,049 Reduced 12.44%
28,494 $5.37 Million
Q4 2019

Feb 07, 2020

SELL
$71.7 - $82.09 $97,440 - $111,560
-1,359 Reduced 4.01%
32,543 $7.59 Million
Q3 2019

Oct 31, 2019

SELL
$61.55 - $75.43 $72,444 - $88,781
-1,177 Reduced 3.36%
33,902 $7.46 Million
Q2 2019

Aug 09, 2019

SELL
$55.74 - $64.41 $97,322 - $112,459
-1,746 Reduced 4.74%
35,079 $6.48 Million
Q1 2019

Apr 24, 2019

SELL
$47.89 - $64.05 $171,110 - $228,850
-3,573 Reduced 8.84%
36,825 $7.05 Million
Q4 2018

Jan 30, 2019

SELL
$46.41 - $56.94 $217,894 - $267,333
-4,695 Reduced 10.41%
40,398 $6.19 Million
Q3 2018

Oct 26, 2018

SELL
$45.7 - $58.03 $443,518 - $563,181
-9,705 Reduced 17.71%
45,093 $7.85 Million
Q2 2018

Aug 10, 2018

SELL
$42.45 - $51.3 $506,555 - $612,162
-11,933 Reduced 17.88%
54,798 $7.98 Million
Q1 2018

May 09, 2018

BUY
$37.19 - $47.45 $45,632 - $58,221
1,227 Added 1.87%
66,731 $9.31 Million
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $2.38 Million - $2.54 Million
65,504
65,504 $7.16 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.